Type 2 & other diabetes

Time at High Risk of Hypoglycemia: Validation of a Consensus-Based Continuous Glucose Monitoring-Metric for Hospitalized Patients

J Diabetes Sci TechnolPublished Secondary analysis of the DIATEC trial

Authors' conclusion

The THRH is strongly associated with hypoglycemia in non-ICU hospitalized patients with type 2 diabetes on basal-bolus insulin.

Study context

Population
Non-ICU inpatients with T2D on basal-bolus insulin therapy, DIATEC trial
Participants
166 inpatients
Comparison
Open continuous glucose monitoring (CGM) vs Point-of-care
  • Open CGMn = 84
  • Point-of-caren = 82
Primary endpoint
Association of time at high risk of hypoglycemia (THRH, 3.9 to 5.6 mmol/L) with TBR (<3.0, 3.0-3.9 and <3.9 mmol/L) and hypoglycemic events
Methodological detailsvalidation study
  • Validation study

Primary result

As reported in the abstract

Change in TBR per 10%-point increase in THRH (CGM-monitored patients)

TBR (<3.0 mmol/L): %-point increase (95% CI 0.06-0.21), P < .001

0.13

TBR (3.0-3.9 mmol/L): %-point increase (95% CI 0.47-0.86), P < .001

0.66

TBR (<3.9 mmol/L): %-point increase (95% CI 0.51-0.97), P < .001

0.74

Further findings

Similar results during day and night analyses and for point-of-care monitored patients, also for hypoglycemic events

Original publication

Time at High Risk of Hypoglycemia: Validation of a Consensus-Based Continuous Glucose Monitoring-Metric for Hospitalized Patients. J Diabetes Sci Technol. Published 11 April 2025. doi:10.1177/19322968251331600

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.